Familial Cancer Control

  • Walter Weber

Part of the ESO Monographs book series (ESO MONOGRAPHS)

Table of contents

  1. Front Matter
    Pages I-XIII
  2. Introduction

    1. W. Weber
      Pages 1-1
  3. Introduction to the Seminar

    1. G. Noseda
      Pages 3-3
  4. Aetiology and Epidemiology

    1. Front Matter
      Pages 5-5
    2. Martin Gebhardt, Mauro Buser, Walter Weber, Susanna Mosimann, Joachim Torhorst, Hansjakob Müller
      Pages 7-11
    3. Rodney J. Scott, Martina Spycher, Walter Weber, Hansjakob Müller
      Pages 13-15
    4. Grant N. Stemmermann
      Pages 23-26
  5. Lynch Syndromes

    1. Front Matter
      Pages 37-37
    2. Henry T. Lynch, Jane F. Lynch, Giuseppe Cristofaro
      Pages 39-43
    3. Giuseppe Cristofaro, Eupremio Carrozzo, Frederick Gentile, Emilio Di Giulio
      Pages 45-49
  6. Treatment

    1. Front Matter
      Pages 51-51
    2. Markus Zuber, Urban Laffer, Felix Harder
      Pages 59-64
    3. S. Martinoli, L. Mariani, A. Goldhirsch
      Pages 65-68
    4. J. M. Haefliger
      Pages 69-72
    5. W. Weber, S. Kubba
      Pages 73-74

About these proceedings


The European School of Oncology came into existence to respond to a need for informa­ tion, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorously multidisciplinary approach which is difficult for the Univer­ sities to put into practice since their system is mainly disciplinary orientated. Secondly, the rate of technological development that impinges on the diagnosis and treatment of cancer has been so rapid that it is not an easy task for medical faculties to adapt their curricula flexibly. With its residential courses for organ pathologies and the seminars on new techniques (laser, monoclonal antibodies, imaging techniques etc.) or on the principal therapeutic controversies (conservative or mutilating surgery, primary or adjuvant chemotherapy, radiotherapy alone or integrated), it is the ambition of the European School of Oncology to fill a cultural and scientific gap and, thereby, create a bridge between the University and Industry and between these two and daily medical practice. One of the more recent initiatives of ESO has been the institution of permanent study groups, also called task forces, where a limited number of leading experts are invited to meet once a year with the aim of defining the state of the art and possibly reaching a consensus on future developments in specific fields of oncology.


DNA breast cancer cancer cancer registry clinical trial colorectal cancer endoscopy epidemiology etiology gastric cancer melanoma prevention screening skin cancer surgery

Editors and affiliations

  • Walter Weber
    • 1
  1. 1.Swiss Cancer LeagueBernSwitzerland

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-642-77582-6
  • Copyright Information Springer-Verlag Berlin Heidelberg 1992
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-77584-0
  • Online ISBN 978-3-642-77582-6
  • About this book